Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2025-12-24 @ 2:32 PM
NCT ID:
NCT02821559
Eligibility Criteria:
Inclusion Criteria:
* performance status (ECOG-PS) of 0 or 1
* patient with histologically proven colorectal cancer with distant metastases
* measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1
* life expectancy \> 12 months
* signed written informed consent
Exclusion Criteria:
* prior chemotherapy at metastatic stage
* presence of brain or meningeal metastases
* other malignancies in the past 5 years with the exception of adequately treated carcinoma in situ of the cervix and squamous or basal cell carcinoma of the skin
* preexisting peripheral neuropathy
* known hypersensitivity to any component of the study treatment
* any psychiatric condition compromising the understanding of information or conduct of the study
* pregnancy, breast-feeding or absence of adequate contraception for fertile patients
* patient under guardianship, curator or under the protection of justice
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02821559
Study Brief:
Protocol Section:
NCT02821559